Dna X (SONM) Income from Continuing Operations (2018 - 2025)
Historic Income from Continuing Operations for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to -$4.8 million.
- Dna X's Income from Continuing Operations fell 8921.18% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.0 million, marking a year-over-year decrease of 16253.66%. This contributed to the annual value of -$34.3 million for FY2024, which is 1033701.49% down from last year.
- Per Dna X's latest filing, its Income from Continuing Operations stood at -$4.8 million for Q3 2025, which was down 8921.18% from -$7.5 million recorded in Q2 2025.
- Dna X's 5-year Income from Continuing Operations high stood at $527000.0 for Q3 2023, and its period low was -$22.3 million during Q4 2024.
- In the last 5 years, Dna X's Income from Continuing Operations had a median value of -$4.2 million in 2022 and averaged -$5.2 million.
- As far as peak fluctuations go, Dna X's Income from Continuing Operations soared by 13277.36% in 2023, and later crashed by 229870.69% in 2024.
- Quarter analysis of 5 years shows Dna X's Income from Continuing Operations stood at -$11.7 million in 2021, then soared by 89.91% to -$1.2 million in 2022, then grew by 21.69% to -$928000.0 in 2023, then tumbled by 2298.71% to -$22.3 million in 2024, then soared by 78.65% to -$4.8 million in 2025.
- Its last three reported values are -$4.8 million in Q3 2025, -$7.5 million for Q2 2025, and $458000.0 during Q1 2025.